Showing results (31-40 of 117) with videos related to

Sort By:
Pageof 12
Frontiers in Medicine|May 16, 2022
A Pilot Study of the Efficacy and Economical Sustainability of Acute Coronavirus Disease 2019 Patient Management in an Outpatient SettingRebecca De Lorenzo, Marco Montagna, Eleonora Bossi, et al.
Breast Cancer Research and Treatment|April 25, 2012
Clinical and pathologic characteristics of BRCA-positive and BRCA-negative male breast cancer patients: results from a collaborative multicenter study in ItalyLaura Ottini, Valentina Silvestri, Piera Rizzolo, et al.
Breast (Edinburgh, Scotland)|December 30, 2017
A possible role of FANCM mutations in male breast cancer susceptibility: Results from a multicenter study in ItalyValentina Silvestri, Piera Rizzolo, Veronica Zelli, et al.
Endocrine Connections|July 24, 2019
Evaluation of CYP17A1 and CYP1B1 polymorphisms in male breast cancer riskPiera Rizzolo, Valentina Silvestri, Virginia Valentini, et al.
International Journal of Cancer|January 8, 2019
Insight into genetic susceptibility to male breast cancer by multigene panel testing: Results from a multicenter study in ItalyPiera Rizzolo, Veronica Zelli, Valentina Silvestri, et al.
European Journal of Cancer (Oxford, England : 1990)|August 8, 2015
Novel and known genetic variants for male breast cancer risk at 8q24.21, 9p21.3, 11q13.3 and 14q24.1: results from a multicenter study in ItalyValentina Silvestri, Piera Rizzolo, Marco Scarnò, et al.
European Journal of Cancer (Oxford, England : 1990)|June 1, 2023
Male breast cancer risk associated with pathogenic variants in genes other than BRCA1/2: an Italian case-control studyAgostino Bucalo, Giulia Conti, Virginia Valentini, et al.
Breast Cancer Research and Treatment|July 20, 2011
Characterization of BRCA1 and BRCA2 splicing variants: a collaborative report by ENIGMA consortium membersMads Thomassen, Ana Blanco, Marco Montagna, et al.
Frontiers in Oncology|December 20, 2018
Contribution of <i>MUTYH</i> Variants to Male Breast Cancer Risk: Results From a Multicenter Study in ItalyPiera Rizzolo, Valentina Silvestri, Agostino Bucalo, et al.
Lung Cancer (Amsterdam, Netherlands)|January 3, 2025
Exploring machine learning tools in a retrospective case-study of patients with metastatic non-small cell lung cancer treated with first-line immunotherapy: A feasibility single-centre experienceFrancesca Rita Ogliari, Alberto Traverso, Simone Barbieri, et al.
Pageof 12